3-(1',2',3',4'-tetrahydro-6'-naphthyl)propenol | 927384-69-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 四氢化萘
• 英文名称: 3-(1',2',3',4'-tetrahydro-6'-naphthyl)propenol
• 英文别名: 3-(5,6,7,8-Tetrahydronaphthalen-2-yl)but-2-en-1-ol
• CAS: 927384-69-8
• 化学式: C₁₄H₁₈O
• 分子量: 202.296
• InChiKey: QBDINUDOOPNEPV-UHFFFAOYSA-N

物化性质

• 沸点：
  362.8±42.0 °C(Predicted)
• 密度：
  1.039±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.7
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.43
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  3-(1',2',3',4'-tetrahydro-6'-naphthyl)propenol 在 manganese(IV) oxide 作用下， 以 正己烷 为溶剂， 反应 60.0h， 生成 trans-3-(1',2',3',4'-tetrahydro-6'-naphthyl)propenal
  参考文献：
  名称：

  摘要：

  Purpose. Optimization of the therapeutic ratio of analogs of the topically active 11-cis, 13-cis-12-hydroxymethylretinoic acid, delta-lactone (1) relative to antihyperproliferation and antihyperkeratinization vs. toxicity. Methods. Nine analogs of 1, in which variations were made in the lipophilic cyclohexenyl moiety or in the lactone ring, were evaluated for topical activity against hyperkeratinization, inhibition of TPA-induced DNA synthesis and for skin irritation. Results. Although more potent lactones than the parent lactone 1 were identified, none possessed the favorable therapeutic ratio associated with 1. Conclusions. The delta-lactone 1 possesses unique molecular features responsible for its desirable therapeutic ratio as an antihyperproliferative and antihyperkeratotic agent. In view of its very low systemic retinoid toxicity and the absence of any systemic toxicity, this lactone may be a good candidate for use in the topical treatment of acne.

  DOI：

  10.1023/a:1016250129246
• 作为产物：
  描述：

  6-乙酰基-1,2,3,4-四氢萘 在 lithium aluminium tetrahydride 、 碘 、 对甲苯磺酸 、 锌 作用下， 以 乙醚 、 苯 为溶剂， 生成 3-(1',2',3',4'-tetrahydro-6'-naphthyl)propenol
  参考文献：
  名称：

  新型功能化芳基乙烯基1,2,4-三恶烷作为有效的抗疟原虫药和抗癌药的设计，合成，结构活性关系和对接研究。

  摘要：

  制备了一系列新的合成的功能化芳基乙烯基1,2,4-三恶烷（8 a – p），并使用SYBR green-I评估了它们对恶性疟原虫耐氯喹Pf INDO菌株的体外抗疟原虫活性。荧光测定。与氯喹（IC）相比，化合物8 g（IC 50 = 0.051μM; SI = 589.41）和8 m（IC 50 = 0.059μM ; SI = 55.93）分别显示出更强的抗血浆活性11倍和> 9倍50 = 0.546μM； SI = 36.63）。不同的计算机对许多靶蛋白的对接研究表明，活性最高的芳基乙烯基1,2,4-三恶烷（8 g和8 m）显示出二氢叶酸还原酶（DHFR）的结合亲和力与氯喹和青蒿琥酯的亲和力相当。在体外的细胞毒性潜力8 - p也针对人肺（A549）和肝（HepG2细胞）肿瘤细胞系评价与永生化的正常肺（BEAS-2B）和肝（LO2）细胞系一起。筛选后，得到五种衍生物。8 a，8 h，8 l，8

  DOI：

  10.1002/cmdc.202000045

文献信息

• FUSED RING COMPOUNDS, PROCESS FOR PRODUCING THE SAME AND USE THEREOF
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP0974584B1

  公开（公告）日：2003-01-15
• US6420375B1
  申请人：——

  公开号：US6420375B1

  公开（公告）日：2002-07-16
• ——
  作者：Anita H. Lewin、Sherry L. Black、Mary E. Bos、R. Richard Goehring、Xina Nair、Gary Whiting、Pamela Bouquin、Geraldine Tetrault、F. Ivy Carroll

  DOI：10.1023/a:1016250129246

  日期：——

  Purpose. Optimization of the therapeutic ratio of analogs of the topically active 11-cis, 13-cis-12-hydroxymethylretinoic acid, delta-lactone (1) relative to antihyperproliferation and antihyperkeratinization vs. toxicity. Methods. Nine analogs of 1, in which variations were made in the lipophilic cyclohexenyl moiety or in the lactone ring, were evaluated for topical activity against hyperkeratinization, inhibition of TPA-induced DNA synthesis and for skin irritation. Results. Although more potent lactones than the parent lactone 1 were identified, none possessed the favorable therapeutic ratio associated with 1. Conclusions. The delta-lactone 1 possesses unique molecular features responsible for its desirable therapeutic ratio as an antihyperproliferative and antihyperkeratotic agent. In view of its very low systemic retinoid toxicity and the absence of any systemic toxicity, this lactone may be a good candidate for use in the topical treatment of acne.
• Design, Synthesis, Structure‐Activity Relationship and Docking Studies of Novel Functionalized Arylvinyl‐1,2,4‐Trioxanes as Potent Antiplasmodial as well as Anticancer Agents
  作者：Mohit K. Tiwari、Paolo Coghi、Prakhar Agrawal、Bharti Rajesh K. Shyamlal、Li Jun Yang、Lalit Yadav、Yuzhong Peng、Richa Sharma、Dharmendra K. Yadav、Dinkar Sahal、Vincent Kam Wai Wong、Sandeep Chaudhary

  DOI：10.1002/cmdc.202000045

  日期：2020.7.3

  against A549 lung cancer cell lines. In silico docking studies of the most active anticancer compounds, 8 l and 8 m , against EGFR were found to validate the wet lab results. In summary, a new series of functionalized aryl‐vinyl‐1,2,4‐trioxanes (8 a –p ) has been shown to display dual potency as promising antiplasmodial and anticancer agents.

  制备了一系列新的合成的功能化芳基乙烯基1,2,4-三恶烷（8 a – p），并使用SYBR green-I评估了它们对恶性疟原虫耐氯喹Pf INDO菌株的体外抗疟原虫活性。荧光测定。与氯喹（IC）相比，化合物8 g（IC 50 = 0.051μM; SI = 589.41）和8 m（IC 50 = 0.059μM ; SI = 55.93）分别显示出更强的抗血浆活性11倍和> 9倍50 = 0.546μM； SI = 36.63）。不同的计算机对许多靶蛋白的对接研究表明，活性最高的芳基乙烯基1,2,4-三恶烷（8 g和8 m）显示出二氢叶酸还原酶（DHFR）的结合亲和力与氯喹和青蒿琥酯的亲和力相当。在体外的细胞毒性潜力8 - p也针对人肺（A549）和肝（HepG2细胞）肿瘤细胞系评价与永生化的正常肺（BEAS-2B）和肝（LO2）细胞系一起。筛选后，得到五种衍生物。8 a，8 h，8 l，8